Frequently asked questions

Commonly Asked Questions

1What is CBD?
CBD is short for cannabidiol. It is just one of many different molecules known as cannabinoids found in the cannabis plant. CBD has many beneficial properties and is commonly used to promote overall wellness.
2What are cannabinoids?
Cannabinoids are active compounds produced by all cannabis plants. They account for most of the benefits of cannabis. Cannabinoids found in plants are technically called phytocannabinoids, while cannabinoids produced by the human body are called endocannabinoids. Cannabinoids interact with the body’s endocannabinoid system (ECS), which promotes homeostasis.
3What is the difference between CBD and hemp?
Hemp is a variety of cannabis that is grown for food and fibers. CBD is a molecular compound found in the plant’s extracts. Salida Hemp Company CBD is extracted from strains of hemp known as PCR hemp, or phytocannabinoid-rich hemp. These strains of hemp are richer in CBD and other cannabinoids and terpenes than the basic hemp plant used by most CBD producers.
4Does CBD contain THC? Will it make me high?
CBD products by law must contain less than 0.3% THC. Salida Hemp Company products contain full spectrum extract, and far less than the legally allowed maximum.
5Is CBD legal for competitive athletes?
Yes. In early 2018 the World Anti-Doping Agency removed CBD from the list of prohibited substances, both in and out of competition. THC and synthetic cannabinoids are still prohibited.
6What makes Salida Hemp Company CBD products special?
We grow our own plants organically just outside of Salida, Colorado (7,300 ft.), and are certified pesticide and heavy metal free. We practice sustainable farming and use as many locally sourcedand organic ingredients as possible in our products. We process our plants into full spectrum extract for the "entourage effect."


References

Booz, George W. “Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress.” Free Radical Biology and Medicine, vol. 51, no. 5, 2011, pp. 1054–1061., doi:10.1016/j.freeradbiomed.2011.01.007.

Elman, Igor, and Scott E. Lukas. “Effects of Cortisol and Cocaine on Plasma Prolactin and Growth Hormone Levels in Cocaine-Dependent Volunteers.” Addictive Behaviors, vol. 30, no. 4, 2005, pp. 859–864., doi:10.1016/j.addbeh.2004.08.019.

Filippis, Daniele De, et al. “Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis.” PLoS ONE, vol. 6, no. 12, 2011, doi:10.1371/journal.pone.0028159.

Gorzalka, Boris B., et al. “Regulation of Endocannabinoid Signaling by Stress: Implications for Stress-Related Affective Disorders.” Neuroscience & Biobehavioral Reviews, vol. 32, no. 6, 2008, pp. 1152–1160., doi:10.1016/j.neubiorev.2008.03.004.

Halawa, Omar I., et al. “Role of Cannabinoids in Pain Management.” Essentials of Pain Medicine, 2018, doi:10.1016/b978-0-323-40196-8.00056-5.

Hammell, D.c., et al. “Transdermal Cannabidiol Reduces Inflammation and Pain-Related Behaviours in a Rat Model of Arthritis.” European Journal of Pain, vol. 20, no. 6, 2015, pp. 936–948., doi:10.1002/ejp.818.

Murillo-Rodriguez, Eric, et al. “Anandamide Enhances Extracellular Levels of Adenosine and Induces Sleep: An In Vivo Microdialysis Study.” Sleep, vol. 26, no. 8, 2003, pp. 943–947., doi:10.1093/sleep/26.8.943.

Nagarkatti, Prakash, et al. “Cannabinoids as Novel Anti-Inflammatory Drugs.” Future Medicinal Chemistry, vol. 1, no. 7, 2009, pp. 1333–1349., doi:10.4155/fmc.09.93.

Pacher, P. “The Endocannabinoid System as an Emerging Target of Pharmacotherapy.” Pharmacological Reviews, vol. 58, no. 3, 2006, pp. 389–462., doi:10.1124/pr.58.3.2.

Patricia H. Reggio, “ Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown”, Current Medicinal Chemistry (2010) 17: 1468. https://doi.org/10.2174/092986710790980005

Xiong, Wei, et al. “Cannabinoids Suppress Inflammatory and Neuropathic Pain by Targeting α3 Glycine Receptors.” The Journal of Experimental Medicine, vol. 209, no. 6, 2012, pp. 1121–1134., doi:10.1084/jem.20120242.